Mobilaser Study to Help With People Who Are Having Problems With Their Gait

Mayo Clinic

Status and phase: Completed; Early Phase 1

Conditions: Parkinson's Disease; Parkinsonism

Treatments: Device: Mobilaser

Study type: Interventional

Funder types: Other

Identifiers

NCT01581645

10-002978

Details and patient eligibility

About

Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.

Full description

Can patients walk faster and have less freezing when using the mobilaser then when not using it

Enrollment: 11 patients

Sex: All

Ages: 30 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Parkinsonian patients with Freezing of Gait or Gait hesitation.
• Must have evidence of bradykinesia ambulating (stride reduction or reduced arm swing)
• Must have a constant caregiver

Exclusion criteria

• No cardiopulmonary contraindications to ambulation, e.g., unstable angina pectoris;
• Severe arthritis;
• Cerebellar or sensory ataxia;
• Recent knee or hip surgery

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

11 participants in 1 patient group

Mobilaser

Experimental group

Description:

Patients will begin by collecting data at home without using the mobilaser. They will then be given the mobilaser to use at home for 6 weeks while they collect data on whether their gait has improved. They will then have to return the Mobilaser to the clinic and collect data at home for 3 days to see if there is a difference.

Treatment:

Device: Mobilaser